康肤酊(Kangfu Tincture) - 在研适应症：湿疹，神经性皮炎_专利_临床

概要

基本信息

药物类型

中药

别名-

靶点-

作用机制-

治疗领域

皮肤和肌肉骨骼疾病

在研适应症

湿疹神经性皮炎

非在研适应症-

原研机构

安徽安科余良卿药业有限公司

在研机构

安徽安科余良卿药业有限公司

非在研机构-

最高研发阶段批准上市

首次获批日期

中国 (2020-05-25),

湿疹神经性皮炎

最高研发阶段(中国)批准上市

特殊审评-

登录后查看时间轴

关联

100 项与康肤酊相关的临床结果

登录后查看更多信息

100 项与康肤酊相关的转化医学

登录后查看更多信息

100 项与康肤酊相关的专利（医药）

登录后查看更多信息

1

项与康肤酊相关的文献（医药）

2017-01-01·Evidence-Based Complementary and Alternative Medicine4区 · 医学

In Vivo Evaluation of Galla chinensis Solution in the Topical Treatment of Dermatophytosis

4区 · 医学

ArticleOA

作者: Ye, Gang ; Yu, Jiankang ; Yin, Lizi ; Zhao, Xinghong ; Yin, Zhongqiong ; Li, Lixia ; Song, Xu ; He, Changliang ; Jia, RenYong ; Yue, Guizhou ; Liang, Xiaoxia ; Zou, Yuanfeng ; Sun, Kai

Aim. Dermatophytosis is one of the main fungal diseases in humans and animals all over the world. Galla chinensis, a traditional medicine, has various pharmacological effects. The goal of this study was to evaluate the treatment effect of Galla chinensis solution (GCS) on dermatophytosis‐infected dogs (Microsporum canis, Microsporum gypseum, and Trichophyton mentagrophytes, resp.). Methods. The treatment effects of GCS were evaluated by mycological cure rates and clinical score comprised of three indices, including inflammation, hair loss, and lesion scale. Results. The results showed that, in the three models of dermatophytosis, GCS significantly (P < 0.05) improved skin lesions and fungal eradication. GCS (10% and 5%) had higher efficacy compared to the positive control (Tujingpi Tincture). The fungal eradication efficacy exceeds 85% after treatment with GCS (10%, 5%, and 2.5%) on day 14. Conclusion. The GCS has antidermatophytosis effect in dogs, which may be a candidate drug for the treatment of dermatophytosis.

100 项与康肤酊相关的药物交易

登录后查看更多信息